Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Subacute and chronic cough in adults" and "Society guideline links: Chronic obstructive pulmonary disease" and "Society guideline links: Hemoptysis" and "Society guideline links: Nontuberculous mycobacteria" and "Society guideline links: Primary ciliary dyskinesia" and "Society guideline links: Cystic fibrosis".)

International

●Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2020 report (published 2019)

United States

●American College of Chest Physicians (CHEST): Treating cough due to non-CF and CF bronchiectasis with nonpharmacological airway clearance (2018)

●American Association for Respiratory Care (AARC): Clinical practice guideline on effectiveness of pharmacologic airway clearance therapies in hospitalized patients (2015)

●American Thoracic Society (ATS)/European Respiratory Society (ERS): Official statement on enhancing implementation, use, and delivery of pulmonary rehabilitation (2015)

●AARC: Clinical practice guideline on effectiveness of nonpharmacologic airway clearance therapies in hospitalized patients (2013)

Europe

●European Respiratory Society (ERS): Guidelines for the management of children and adolescents with bronchiectasis (2021)

●ERS/Thoracic Society of Australia and New Zealand (TSANZ): Statement on the management of reproduction and pregnancy in women with airways diseases (2020)

●ERS: Guidelines for the management of adult bronchiectasis (2017)

●American Thoracic Society (ATS)/ERS: Official statement on enhancing implementation, use, and delivery of pulmonary rehabilitation (2015)

United Kingdom

●British Thoracic Society (BTS): Guideline for bronchiectasis in adults (2019)

●National Institute for Health and Care Excellence (NICE): Guideline on bronchiectasis (non-cystic fibrosis), acute exacerbation – Antimicrobial prescribing (2018)

●BTS: Quality standards for pulmonary rehabilitation in adults (2014)

●BTS: Guideline on pulmonary rehabilitation in adults (2013)

Australia-New Zealand

●European Respiratory Society (ERS)/Thoracic Society of Australia and New Zealand (TSANZ): Statement on the management of reproduction and pregnancy in women with airways diseases (2020)

●Lung Foundation Australia and TSANZ: Australia and New Zealand pulmonary rehabilitation clinical practice guidelines (2017)

●TSANZ: Clinical practice guideline on chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand (2014, updated 2015)